Michel Johnson

1.1k total citations
37 papers, 966 citations indexed

About

Michel Johnson is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Toxicology. According to data from OpenAlex, Michel Johnson has authored 37 papers receiving a total of 966 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cellular and Molecular Neuroscience, 11 papers in Molecular Biology and 9 papers in Toxicology. Recurrent topics in Michel Johnson's work include Neurotransmitter Receptor Influence on Behavior (25 papers), Neuropeptides and Animal Physiology (16 papers) and Receptor Mechanisms and Signaling (9 papers). Michel Johnson is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (25 papers), Neuropeptides and Animal Physiology (16 papers) and Receptor Mechanisms and Signaling (9 papers). Michel Johnson collaborates with scholars based in United States and China. Michel Johnson's co-authors include James W. Gibb, Glen R. Hanson, Donna M. Stone, Lloyd G. Bush, Hyun Kyoon Lim, Ikram Elayan, Kalpana Merchant, Anita A. Letter, Nanda Singh and R. L. Foltz and has published in prestigious journals such as Annals of the New York Academy of Sciences, American Journal of Obstetrics and Gynecology and Critical Care Medicine.

In The Last Decade

Michel Johnson

36 papers receiving 946 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michel Johnson United States 18 824 343 324 200 171 37 966
S C Wall United States 10 1.1k 1.3× 630 1.8× 245 0.8× 210 1.1× 168 1.0× 11 1.3k
Harry W. Broening United States 14 1.0k 1.3× 276 0.8× 385 1.2× 183 0.9× 218 1.3× 20 1.3k
A Richard Green United Kingdom 11 367 0.4× 116 0.3× 308 1.0× 213 1.1× 155 0.9× 11 625
Viviane Hechler France 19 779 0.9× 220 0.6× 537 1.7× 67 0.3× 98 0.6× 24 1.0k
Michael G. Bankson United States 8 534 0.6× 150 0.4× 281 0.9× 243 1.2× 102 0.6× 8 638
Verónica Sánchez Spain 12 521 0.6× 96 0.3× 483 1.5× 322 1.6× 251 1.5× 19 830
Lisa M. McFadden United States 14 503 0.6× 247 0.7× 212 0.7× 136 0.7× 58 0.3× 37 736
Rómeó D. Andó Hungary 15 305 0.4× 146 0.4× 111 0.3× 109 0.5× 156 0.9× 28 730
S. Stevens Negus United States 21 1.1k 1.3× 737 2.1× 128 0.4× 95 0.5× 124 0.7× 35 1.3k
John J. Rutter United States 8 424 0.5× 171 0.5× 68 0.2× 75 0.4× 121 0.7× 10 499

Countries citing papers authored by Michel Johnson

Since Specialization
Citations

This map shows the geographic impact of Michel Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Johnson more than expected).

Fields of papers citing papers by Michel Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Johnson. The network helps show where Michel Johnson may publish in the future.

Co-authorship network of co-authors of Michel Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Johnson. A scholar is included among the top collaborators of Michel Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Johnson. Michel Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alexander, Matthew D., et al.. (2023). Real-Time Monitoring and Modulation of Blood Pressure in a Rabbit Model of Ischemic Stroke. Journal of Visualized Experiments. 1 indexed citations
2.
Johnson, Michel, et al.. (1995). Body temperature effect on methylenedioxymethamphetamine-induced acute decrease in tryptophan hydroxylase activity. European Journal of Pharmacology Environmental Toxicology and Pharmacology. 293(4). 447–453. 27 indexed citations
3.
Hanson, Glen R., Nanda Singh, Kalpana Merchant, Michel Johnson, & James W. Gibb. (1995). The role of NMDA receptor systems in neuropeptide responses to stimulants of abuse. Drug and Alcohol Dependence. 37(2). 107–110. 31 indexed citations
4.
Johnson, Michel, Glen R. Hanson, James W. Gibb, John C. Adair, & Francis Filloux. (1994). Effect of neonatal hypoxia-ischemia on nigro-striatal dopamine receptors and on striatal neuropeptide Y, dynorphin A and substance P concentrations in rats. Developmental Brain Research. 83(1). 109–118. 31 indexed citations
5.
Gygi, Steven P., James W. Gibb, Michel Johnson, & Glen R. Hanson. (1993). Blockade of tachykinin NK1 receptors by CP-96345 enhances dopamine release and the striatal dopamine effects of methamphetamine in rats. European Journal of Pharmacology. 250(1). 177–180. 18 indexed citations
6.
Gibb, James W., et al.. (1993). Effects of nimodipine on the amphetamine- and methamphetamine-induced decrease in tryptophan hydroxylase activity. European Journal of Pharmacology. 250(3). 395–402. 4 indexed citations
7.
Gibb, James W., Michel Johnson, Donna M. Stone, & Glen R. Hanson. (1993). Mechanisms Mediating Biogenic Amine Deficits Induced by Amphetamine and Its Congeners. PsycEXTRA Dataset. 136. 226–36; discussion 236. 6 indexed citations
8.
Hanson, Glen R., Nanda Singh, Kalpana Merchant, et al.. (1992). Responses of Limbic and Extrapyramidal Neurotensin Systems to Stimulants of Abuse. Annals of the New York Academy of Sciences. 668(1). 165–172. 26 indexed citations
9.
Johnson, Michel, et al.. (1992). Effect of flunarizine and nimodipine on the decrease in tryptophan hydroxylase activity induced by methamphetamine and 3,4-methylenedioxymethamphetamine.. Journal of Pharmacology and Experimental Therapeutics. 261(2). 586–591. 13 indexed citations
10.
Johnson, Michel, et al.. (1992). MK‐801 Blocks the Changes in Neurotensin Concentrations Induced by Methamphetamine, 3,4‐Methylenedioxymethamphetamine, Cocaine, and GBR 12909a. Annals of the New York Academy of Sciences. 668(1). 350–352. 1 indexed citations
11.
Hanson, Glen R., et al.. (1992). Response of monoaminergic and neuropeptide systems to 4-methylaminorex: a new stimulant of abuse. European Journal of Pharmacology. 218(2-3). 287–293. 9 indexed citations
12.
Johnson, Michel, Lloyd G. Bush, James W. Gibb, & Glen R. Hanson. (1991). Role of N--- (NMDA) receptors in the response of extrapyramidal neurotensin and dynorphin A systems to cocaine and GBR 12909. Biochemical Pharmacology. 41(4). 649–652. 18 indexed citations
13.
Johnson, Michel, et al.. (1991). Norepinephrine does not contribute to methamphetamine-induced changes in hippocampal serotonergic system. Neuropharmacology. 30(6). 617–622. 4 indexed citations
14.
Johnson, Michel, Lloyd G. Bush, James W. Gibb, & Glen R. Hanson. (1991). Blockade of the 3,4-methylenedioxymethamphetamine-induced changes in neurotensin and dynorphin A systems. European Journal of Pharmacology. 193(3). 367–370. 24 indexed citations
15.
Johnson, Michel, et al.. (1990). Neurochemical basis of neurotoxicity.. PubMed. 11(2). 317–21. 67 indexed citations
16.
Gibb, James W., Michel Johnson, Donna M. Stone, & Glen R. Hanson. (1990). MDMA: Historical Perspectives. Annals of the New York Academy of Sciences. 600(1). 601–611. 25 indexed citations
17.
Gibb, James W., Donna M. Stone, Michel Johnson, & Glen R. Hanson. (1989). Role of Dopamine in the Neurotoxicity Induced by Amphetamines and Related Designer Drugs. PsycEXTRA Dataset. 94. 161–78. 6 indexed citations
18.
Johnson, Michel, Glen R. Hanson, & James W. Gibb. (1989). Effect of MK-801 on the decrease in tryptophan hydroxylase induced by methamphetamine and its methylenedioxy analog. European Journal of Pharmacology. 165(2-3). 315–318. 47 indexed citations
19.
Johnson, Michel, Glen R. Hanson, & James W. Gibb. (1988). Effects of dopaminergic and serotonergic receptor blockade on neurochemical changes induced by acute administration of methamphetamine and 3,4-methylenedioxymethamphetamine. Neuropharmacology. 27(11). 1089–1096. 12 indexed citations
20.
Johnson, Michel, Glen R. Hanson, & James W. Gibb. (1987). Effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE) on central serotonergic and dopaminergic systems of the rat. Biochemical Pharmacology. 36(23). 4085–4093. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S C Wall Breakdown of academic impact, for papers by Harry W. Broening Breakdown of academic impact, for papers by A Richard Green Breakdown of academic impact, for papers by Viviane Hechler Breakdown of academic impact, for papers by Michael G. Bankson Breakdown of academic impact, for papers by Verónica Sánchez Breakdown of academic impact, for papers by Lisa M. McFadden Breakdown of academic impact, for papers by Rómeó D. Andó Breakdown of academic impact, for papers by S. Stevens Negus Breakdown of academic impact, for papers by John J. Rutter
Rankless by CCL
2026